ARID5B influences antimetabolite drug sensitivity and prognosis of acute lymphoblastic leukemia

PURPOSE: Treatment outcomes for childhood acute lymphoblastic leukemia (ALL) have improved steadily, but a significant proportion of patients still experience relapse due to drug resistance, which is partly explained by inherited and/or somatic genetic alternations. Recently, we and others have iden...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cancer Res
Glavni autori: Xu, Heng, Zhao, Xujie, Bhojwani, Deepa, Shuyu, E, Goodings, Charnise, Zhang, Hui, Seibel, Nita L., Yang, Wentao, Li, Chunliang, Carroll, William L., Evans, William, Yang, Jun J.
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7574699/
https://ncbi.nlm.nih.gov/pubmed/31573954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-0190
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items